Fetal-derived atherosclerosis susceptibility model and construction method and application thereof
Patent Information
- Application Number
- CN202610326029.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-17
- Publication Date
- 2026-05-19
AI Technical Summary
Existing animal models of atherosclerosis cannot simulate fetal characteristics caused by adverse intrauterine environmental exposure, which limits in-depth exploration of the developmental origin mechanism of atherosclerosis and research on early life intervention strategies.
A fetal atherosclerosis susceptibility model was established by subcutaneously injecting dexamethasone into healthy ApoE-/- mice at 16-17 days of gestation, combined with feeding F1 generation mice with a high-fat, high-cholesterol diet. Plaque morphology and biochemical indicators were then examined.
A fetal susceptibility model for atherosclerosis was successfully constructed, which significantly aggravated atherosclerotic lesions in offspring. This provides a research tool with more typical pathological features and faster disease progression, supporting research on the mechanisms of atherosclerosis progression and drug evaluation.
Smart Images

Figure CN122056256A_ABST